Elif Kulaksizoglu

Elif Kulaksizoglu

Auto-generated profile, based on publicly available information

Elif Kulaksizoglu

Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University School of Medicine Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
LGLena Gamboa
Lena Gamboa
AZAli H. Zamat
Ali H. Zamat
CTChloé A. Thiveaud
Chloé A. Thiveaud
HLHee Jun Lee
Hee Jun Lee
EKElif Kulaksizoglu
Elif Kulaksizoglu
GKGabriel A. Kwong
Gabriel A. Kwong

27 August 2025 in bioRxiv
Verified
Preprint
Open access
SGStephanie A Gaglione
Stephanie A Gaglione
JKJonathan Krog
Jonathan Krog
FKFrances R Keer
Frances R Keer
EFEmma N Finburgh
Emma N Finburgh
EKElif Kulaksizoglu
Elif Kulaksizoglu
MBMichael E Birnbaum
Michael E Birnbaum
T cell receptor (TCR) specificity is central to the efficacy of T cell therapies, yet scalable methods to map how TCR sequences shape antigen recognition remain limited. To address this, we introduce VelociRAPTR, a library-on-library approach that combines yeast-displayed TCR libraries with pMHC-displaying virus-like particles (pMHC-VLPs) to rapidly screen millions of TCR-antigen interactions. We show that pMHC-VLPs efficiently bind TCRs on yeast and generate equivalent data to recombinantly produced pMHC protein. We then apply VelociRAPTR to screen 47 million variants of the A6 and 868 TCRs against 92 pMHCs simultaneously, mutating both the CDR3 loops and cognate peptides. The resulting CDR3-pMHC maps reveal biased recognition patterns, where mutations to CDR3 loops can selectively constrain or broaden specificity to peptide analogs. These insights provide a foundation for engineering TCRs with defined pMHC binding profiles and improving models that predict TCR-antigen interactions, including the prediction of off-target recognition. By coupling the scale of yeast display with the modularity of VLPs, VelociRAPTR offers a generalizable strategy for generating deep, high-throughput protein-protein interaction data.

19 August 2026 in Advanced Materials
Verified
Journal Article
Open access
PDF file
MKMyeongsoo Kim
Myeongsoo Kim
AZAli Zamat
Ali Zamat
MCMelissa Cadena
Melissa Cadena
CTChloé Thiveaud
Chloé Thiveaud
RSRiya Sen
Riya Sen
SEStanislav Emelianov
Stanislav Emelianov
Noninvasive monitoring and control of CAR T cells against heterogeneous solid tumors remain major challenges in understanding and improving treatment response. To address this, membrane‐bound plasmonic transducers, composed of plasmonically coupled gold nanospheres in an anisotropic framework, were developed for multimodal photoacoustic imaging and localized thermal modulation of CAR T cell activity. These transducers exhibit approximately 90% absorption efficiency and photostability under laser fluences exceeding 20 mJ cm −2 , delivering photoacoustic and thermal responses over multiple lasing cycles. Membrane‐bound transducers on CAR T cells thus enable photoacoustic and thermal responsiveness upon laser excitation without compromising key cellular functions. In heterogeneous HER2‐expressing breast tumor models, longitudinal photoacoustic imaging enabled prospective stratification of tumors based on early T cell trafficking, predicting responders versus nonresponders with high sensitivity and specificity. Moreover, transducer‐mediated thermal modulation of intratumoral CAR T cells engineered with thermogenetic circuits to secrete T cell engagers redirected cytotoxicity toward antigen‐negative tumors, overcoming antigen escape and consequently enhancing therapy. Taken together, we demonstrate a strategy to noninvasively monitor and control CAR T cells against heterogeneous solid tumors via membrane‐bound multimodal transducers.